Sims Andrew John Hugh MacIntyre — SEC Form 4 filings
SEC reporting owner CIK 1802687. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-26 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 29,000 shares, $25,405 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: purchase of 20,000 shares @ $0.51 ($10,200) in PLUS THERAPEUTICS, INC., filed 2025-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PLUS THERAPEUTICS, INC. (PSTV) | Chief Financial Officer | 14 | 3 legs · 29,000 sh · $25,405 | — | 26 |
Form 4 filings — Sims Andrew John Hugh MacIntyre
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 1,533 @ $0 · Option exercise (M): 1,165 @ $0 · Option exercise (M): 287 @ $0 · Option exercise (M): 1,533 (derivative) @ $0 · Option exercise (M): 1,165 (derivative) @ $0 · Option exercise (M): 287 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,443 (derivative) @ $0 · Grant/award (A): 3,443 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 38,323 @ $0 · Option exercise (M): 29,129 @ $0 · Option exercise (M): 38,323 (derivative) @ $0 · Option exercise (M): 29,129 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 349,542 (derivative) @ $0 · Grant/award (A): 349,541 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 38,323 @ $0 · Option exercise (M): 38,323 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 20,000 @ $0.51 | EDGAR |
| 2025-10-03 | 4/A | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 1,379,636 (derivative) @ $0 · Grant/award (A): 459,878 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 38,323 @ $0 · Option exercise (M): 38,323 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 1,379,636 (derivative) @ $0 · Grant/award (A): 459,878 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 60,020 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 46,074 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,098 @ $1.27 | EDGAR |
| 2024-05-10 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Purchase (P): 4,902 @ $2.04 · Grant/award (A): 9,804 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 18,933 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1802687 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →